Synergistic Oncolytic Virus System for Enhanced Cancer Treatment

A novel oncolytic virus system integrating AI, IoT, blockchain, and advanced materials to enhance cancer treatment outcomes and patient care

The original patent disclosed an oncolytic virus growth method and antitumor agent, but its effectiveness was limited by the lack of personalized treatment strategies, inefficient data management, and inadequate delivery systems. The new inventive concept addresses these limitations by combining the oncolytic virus with cutting-edge technologies to create a more powerful and targeted cancer treatment system

The system comprises an oncolytic virus, a blockchain-based data management system for secure and transparent patient information tracking, a machine learning algorithm for predicting optimal treatment regimens, and an IoT-based sensor for real-time monitoring of patient vital signs. Additionally, the system incorporates nanoparticle-based delivery systems and graphene-based materials for targeted and efficient delivery of the oncolytic virus. The AI-based recommendation engine selects optimal treatment strategies based on patient data and treatment outcomes, ensuring personalized care

The new claims introduce a synergistic combination of distinct technologies, including AI, IoT, blockchain, and advanced materials, which are not obvious from the original patent. The integration of these technologies enables a more effective, targeted, and personalized cancer treatment system

Alternative embodiments of the inventive concept could include the use of different AI algorithms, varying IoT sensor configurations, or the incorporation of other advanced materials. Additionally, the system could be adapted for use in treating other diseases or conditions

The inventive concept has significant commercial potential in the cancer treatment market, with potential applications in personalized medicine, precision oncology, and healthcare technology. The market for cancer treatment is projected to grow significantly in the coming years, driven by the increasing incidence of cancer and the need for more effective treatment options